|
Federal Funding to Affymetrix (1993–2003) |
|||||||
| Award Number |
AvgAnnual (in $K) |
Start |
End |
Total (in $K) |
Government Entity |
SBIR |
Brief Description |
|
|
|||||||
| FG0392ER81275 |
137.5 |
Jul-92 |
May-95 |
550.0 |
Basic energy sciences (Dept. of Energy) |
Y |
SBIR phase I: develop spatially defined oligonucleotide arrays |
| R01HG000813 |
465.8 |
Sep-93 |
Aug-95 |
NA |
National Human Genome Research Institute |
N |
The long term goals of this proposal are to construct spatially defined arrays of oligonucleotide probes and to study the feasibility of using these arrays in applications of sequencing DNA by hybridization. A multidisciplinary research program is proposed which will integrate the necessary expertise in photolithography, photochemistry, synthetic chemistry, detection technology, informatics and applications to large scale DNA sequencing. |
| F32HG000105 |
20.3 |
Jun-93 |
Aug-96 |
NA |
National Human Genome Research Institute |
N |
NA |
| R43AI036809 |
37.5 |
Jul-94 |
Jan-95 |
75.0 |
National Institute of Allergy and Infectious Diseases |
Y |
Rapid detection of HIV drug resistance |
| 70NANB5H1031 |
5,246.3 |
Feb-95 |
Jan-00 |
31,478 |
Advanced Technology Program |
N |
Capillary-array electrophoresis, which separates and sizes DNA fragments, for use in a compact, reusable system for use with patient blood samples in labs and hospitals. Lawrence Livermore National Laboratory, Stanford University, the University of California (Berkeley), the California Institute of Technology, and the University of Washington also will work on the project. |
| R43CA067604 |
100.0 |
Mar-95 |
Sep-95 |
100.0 |
National Cancer Institute |
Y |
Detection of mutations in human p53, msh2, mlh1 genes |
| R43DA010389 |
50.0 |
Sep-95 |
Mar-96 |
100.0 |
National Institute on Drug Abuse |
Y |
Typing human cytochrome p450 genes using DNA chips |
| A64472D |
27.6 |
Jul-01 |
Jul-01 |
27.6 |
Human health and performance (NASA) |
N |
Studying the rat genome |
| P01HG001323 |
1,377.5 |
Sep-95 |
Aug-98 |
NA |
National Human Genome Research Institute |
N |
Human genome sequencing and mapping with dna probe arrays |
| R41CA075675 |
49.8 |
Jul-97 |
Sep-98 |
99.7 |
National Cancer Institute |
N |
Genotype for radiation sensitivity in cancer patients |
| R43AI040400 |
50.0 |
Sep-96 |
Mar-97 |
100.0 |
National Institute of Allergy and Infectious Diseases |
Y |
Chip based genotyping of mycobacterium drug resistance |
| R43CA081949 |
133.3 |
Jul-99 |
Sep-99 |
133.3 |
National Cancer Institute |
Y |
Reverese engineering biological signal transduction networks |
| R43HD038622 |
50.0 |
Sep-00 |
Aug-01 |
100.0 |
National Institute of Child Health and Human Development |
Y |
Gene expression in endometriosis |
| R43HG001481 |
33.3 |
Apr-96 |
Oct-97 |
33.3 |
National Human Genome Research Institute |
Y |
Mutation screening of the human mitochondrial genome |
| R43NS036491 |
50.0 |
Jul-97 |
Jan-98 |
100.0 |
National Institute of Neurological Disorders and Stroke |
Y |
Cytokine message monitoring in oral tolerance |
| R44AI036809 |
250.0 |
Aug-95 |
Jul-97 |
372.6 |
National Institute of Allergy and Infectious Diseases |
Y |
Rapid detection of HIV 1 drug resistance |
| R44CA067604 |
244.3 |
Mar-96 |
Feb-98 |
359.3 |
National Cancer Institute |
Y |
Phase II of earlier project to develop a rapid and efficient method for detecting mutations on the human p53, msh2 and mlh1 genes |
| R44DA010389 |
163.9 |
Sep-96 |
Aug-98 |
205.5 |
National Institute on Drug Abuse |
Y |
Phase II of earlier project for typing human cytochrome p450 genes using DNA chips |
| R44DK053325 |
237.7 |
Jul-97 |
Sep-99 |
86.7 |
National Institute of Diabetes and Digestive and Kidney Diseases |
Y |
Genomic responses to hormone signaling |
| R44HG001481 |
249.2 |
Jul-97 |
Aug-99 |
368.5 |
National Human Genome Research Institute |
Y |
Continuation of mutation screening of the human mitochondrial genome project |
| U01HG003147 |
661.0 |
Sep-03 |
Jul-05 |
985.5* |
National Human Genome Research Institute |
N |
Mapping sites of transcription and regulation |
Lenoir and Giannella Journal of Biomedical Discovery and Collaboration 2006 1:11 doi:10.1186/1747-5333-1-11 |
|||||||